Speaker

Andrew Steinsapir

Director - Gene Therapy Program Lead, Deerfield

Andrew Steinsapir, Director - Gene Therapy Program Lead at Deerfield, is speaking at 8th CNS Drug Delivery Summit (Boston, United States of America, 1–3 Dec 2026) in the session “Panel Discussion: The Investment Landscape for CNS Delivery Technologies: Trends, Drivers & Funding Priorities”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

8th CNS Drug Delivery Summit
1–3 Dec 2026Boston, United States of America
- PanelPanel Discussion: The Investment Landscape for CNS Delivery Technologies: Trends, Drivers & Funding PrioritiesWith Lipa Shah, Miles Gerson, Akihiro Furukawa, Hugh Nuthall, Ross Jeggo

More speakers at 8th CNS Drug Delivery Summit

Mathias Schmidt
President & Chief Executive Officer, ArmaGen & JCR Pharmaceuticals
Janelle Arrambide
Head of Device Clinical, Biogen
Susana Correia
Director, Neuromuscular Research, Dyne Therapeutics
Ajit D’Souza
Executive Director, Drug Delivery & Devices DDCS, Eli Lilly
Andrew East
Head of IDU Device Development & Manufacturing, Biogen
Kaitlyn Eddy
Principal Engineer, Delivery, Device, and Connected Solutions (DDCS), Eli Lilly

See all 23 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Andrew Steinsapir, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].